Deitelzweig S, Luo X, Gupta K, Trocio J, Mardekian J, Curtice T, Lingohr-Smith M, Menges B, Lin J. Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients. Current Medical Research and Opinion. 2017;33:1745-1754. http://dx.doi.org/10.1080/03007995.2017.1334638.
When the above article was first published, Figures 1, 2 and 3 contained an error. The corrected figures are presented below.
Figure 1. Selection of patients for study cohorts treated with apixaban and rivaroxaban. AF: atrial fibrillation; NVAF: nonvalvular atrial fibrillation; PSM: propensity score matching.
Figure 2. Selection of patients for study cohorts treated with apixaban and dabigatran. AF: atrial fibrillation; NVAF: nonvalvular atrial fibrillation; PSM: propensity score matching.
The authors apologise for this error.
Figure 3. Selection of patients for study cohorts treated with apixaban and warfarin. AF: atrial fibrillation; NVAF: nonvalvular atrial fibrillation; PSM: propensity score matching.
